Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03671499 · ClinicalTrials.gov registry record · NA

A Study for Testing Text Messaging and Newsletter as a Strategy for Interrupting Sedentary Behavior

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT03671499 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03671499, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The study will examine the possibility of reducing sedentary behavior (SB) in African Americans with MS. SB consists of any waking activities that are done lying or sitting and do not demand significant physical effort (e.g., watching television, using the computer). SB is a major public health issue because it is associated with mortality and higher probabilities of presenting with health conditions and morbidity. There is indication that SB is related to physical disability, which is the inability of performing daily activities independently. This outcome is of high concern for persons with MS, especially those from underserved groups, such as African Americans. Thus, reducing the amount of time that people with MS spend in SB is important, but it is hard to find ways of doing so in large groups of people with MS. One possibility is to use text-messages to inform people about the necessity and benefits of interrupting SB by standing up, walking, or doing another activity. Text-messages are an ideal way to prompt behavior change because almost everyone owns a cellphone/smartphone in today's world. Considering this potential, the investigators will be studying whether or not it is possible to have a small group of African Americans with MS spend less time in SB by sending informative text-messages prompting individuals to stand-up and move around. This study will be used to inform the development of a much larger study that will aim to reduce SB in a very large sample of persons with MS.

Interventions

  • BEHAVIORAL Social Cognitive Theory based text messages

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2018-03-27
Est. Completion 2019-10-25
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT03671499

The ClinicalTrials.gov registry entry for NCT03671499 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Social Cognitive Theory based text messages is the first listed.

NCT03671499 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03671499 about?

NCT03671499 is a clinical study titled "A Study for Testing Text Messaging and Newsletter as a Strategy for Interrupting Sedentary Behavior". The study will examine the possibility of reducing sedentary behavior (SB) in African Americans with MS. SB consists of any waking activities that are done lying or sitting and do not demand significant physical effort (e.g., watching television, using the computer). SB is a major public health issu...

What is the current status of trial NCT03671499?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-03-27. Estimated completion is 2019-10-25.

What interventions are being tested in trial NCT03671499?

The interventions under investigation include: Social Cognitive Theory based text messages (BEHAVIORAL).

Who is sponsoring clinical trial NCT03671499?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.